Here's the live share price of Cohance Lifesciences along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Source: Dion Global
Source: Dion Global
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Cohance Lifesciences | -3.29 | -0.66 | 3.46 | 52.42 | -55.04 | -4.91 | -3.71 |
| Sun Pharmaceutical Industries | -3.00 | -4.81 | 1.92 | 0.93 | 13.97 | 17.17 | 18.75 |
| Divi's Laboratories | 2.48 | 9.14 | 40.60 | 48.59 | 54.75 | 35.06 | 12.89 |
| Torrent Pharmaceuticals | 2.58 | 1.74 | 8.74 | 11.93 | 39.50 | 38.88 | 26.07 |
| Zydus Lifesciences | -0.13 | -7.02 | 1.37 | 22.14 | 7.14 | 21.27 | 15.05 |
| Cipla | -1.44 | -6.61 | -1.71 | 3.00 | -13.27 | 3.27 | 7.51 |
| Laurus Labs | 7.08 | 7.02 | 41.33 | 88.40 | 119.94 | 72.44 | 24.99 |
| Aurobindo Pharma | 1.34 | 0.63 | 13.80 | 27.58 | 53.07 | 24.35 | 17.88 |
| Dr. Reddy's Laboratories | 0.61 | -3.17 | -8.86 | -11.96 | -11.80 | 0.75 | 3.31 |
| Lupin | -0.71 | -7.45 | -8.58 | -11.07 | 2.61 | 22.56 | 16.33 |
| Mankind Pharma | -2.21 | -6.09 | -4.31 | 3.11 | -11.74 | 8.49 | 9.84 |
| Glenmark Pharmaceuticals | -0.42 | 6.37 | 11.21 | 7.04 | 13.43 | 43.73 | 36.03 |
| Biocon | -1.59 | -8.81 | -6.59 | -0.45 | 7.08 | 13.55 | 2.03 |
| Alkem Laboratories | -1.97 | -6.96 | -3.90 | -6.58 | -6.56 | 11.87 | 5.85 |
| Abbott India | -1.93 | -9.16 | -2.67 | -4.21 | -17.42 | 3.77 | 3.60 |
| Anthem Biosciences | 0.44 | 6.84 | 18.94 | 46.51 | 12.56 | 8.70 | 5.13 |
| Ipca Laboratories | 0.10 | 11.34 | 24.04 | 26.13 | 49.61 | 29.94 | 8.68 |
| Gland Pharma | -0.08 | 1.22 | 29.58 | 76.88 | 44.99 | 21.05 | -5.12 |
| GlaxoSmithKline Pharmaceuticals | -4.34 | 8.03 | 33.45 | 13.01 | 1.99 | 24.56 | 12.96 |
| Ajanta Pharma | 2.10 | -0.16 | 13.03 | 13.29 | 37.17 | 27.25 | 19.98 |
Source: Dion Global
Over the last one year, Cohance Lifesciences has declined 55.04% compared to peers like Sun Pharmaceutical Industries (13.97%), Divi's Laboratories (54.75%), Torrent Pharmaceuticals (39.50%). From a 5 year perspective, Cohance Lifesciences has underperformed peers relative to Sun Pharmaceutical Industries (18.75%) and Divi's Laboratories (12.89%).
Source: Dion Global
| Day | SMA | EMA |
|---|---|---|
| 5 | 449.21 | 445.77 |
| 10 | 453.18 | 449.07 |
| 20 | 453.44 | 449.82 |
| 50 | 444.57 | 444.56 |
| 100 | 440.45 | 442.03 |
| 200 | 423.86 | 495.69 |
Source: Dion Global
In the latest quarter, Cohance Lifesciences remained same as its previous close in promoter holding, while DII stake decreased to 20.09%, FII holding rose to 6.50%, and public shareholding moved up to 15.92% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| 52,00,000 | 1.1 | 229.14 | |
| 41,43,548 | 0.16 | 176.12 | |
| 40,13,973 | 0.85 | 170.61 | |
| 32,85,254 | 0.84 | 139.64 | |
| 28,08,197 | 1 | 119.36 | |
| 27,62,648 | 0.64 | 117.43 | |
| 24,53,891 | 0.84 | 104.3 | |
| 23,01,367 | 0.16 | 97.82 | |
| 22,14,332 | 0.18 | 94.12 | |
| 22,00,000 | 1.73 | 93.51 |
Source: Dion Global
* Excluding Index & Arbitrage Funds
Date Time | Announcement |
|---|---|
| Sep 05, 2026, 06:00 AM IST IST | Cohance Lifesciences - Completion Of USFDA Inspection |
| Sep 04, 2026, 01:41 AM IST IST | Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release |
| Sep 04, 2026, 01:23 AM IST IST | Cohance Lifesciences - Board Meeting Outcome for Outcome Of The Committee Meeting |
| Aug 27, 2026, 10:53 PM IST IST | Cohance Lifesciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation |
| Aug 27, 2026, 01:45 AM IST IST | Cohance Lifesciences - Business Responsibility and Sustainability Reporting (BRSR) |
Source: Dion Global
Cohance Lifesciences Ltd. is a Public Limited Listed company incorporated on 06/11/2018 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24299MH2018PLC422236 and registration number is 422236. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company's Total Operating Revenue is Rs. 2030.50 Cr. and Equity Capital is Rs. 38.26 Cr. for the Year ended 31/03/2026.
Source: Dion Global
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Cohance Lifesciences is ₹441.55 as on Sep 11, 2026.
The Cohance Lifesciences is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Cohance Lifesciences is ₹16,893.59 Cr as on Sep 11, 2026.
Today’s highest and lowest price of Cohance Lifesciences are ₹447.00 and ₹434.40.
The 52-week high/low is the highest and lowest price at which Cohance Lifesciences stock has traded in the past 52-week or nearly a year. The 52-week high of Cohance Lifesciences is ₹1,006.90 and 52-week low of Cohance Lifesciences is ₹267.85 as on Sep 11, 2026.
The Cohance Lifesciences has shown returns of -0.92% over the past day, -4.89% for the past month, 4.31% over 3 months, -55.63% over 1 year, -5.24% across 3 years, and -3.71% over 5 years.
P/E ratio of and PB ratio of Cohance Lifesciences are 159.03 and 4.37 on Sep 11, 2026. While the company gives a dividend yield of 0.00 per annum.
Source: Dion Global